drug

SION-109

Phase 1updated 3mo ago

by $SION Sionna Therapeutics, Inc.

Phase 1

community read0 votes

indications

Cystic Fibrosis

all catalysts(0)

nothing on the calendar yet

Trials studying SION-109

phase1Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.recruitingn=144

News(1)

Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for Vertex
Sionna Therapeutics has axed a cystic fibrosis add-on program after flunking a phase 2 trial, eliminating a would-be challenger to Vertex Pharmaceuticals’ empire. The biotech plans to “take actions…
fiercebiotech · 7d ago

Data sources

ClinicalTrials.gov

last refreshed 31m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

SION-109

Phase 1updated 3mo ago

by $SION Sionna Therapeutics, Inc.

Phase 1

community read0 votes

indications

Cystic Fibrosis

all catalysts(0)

nothing on the calendar yet

Trials studying SION-109

phase1Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.recruitingn=144

News(1)

Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for Vertex
Sionna Therapeutics has axed a cystic fibrosis add-on program after flunking a phase 2 trial, eliminating a would-be challenger to Vertex Pharmaceuticals’ empire. The biotech plans to “take actions…
fiercebiotech · 7d ago

Data sources

ClinicalTrials.gov

last refreshed 31m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

SION-109

indications

all catalysts(0)

Trials studying SION-109

News(1)

Report a data issue

comments(0)

SION-109

indications

all catalysts(0)

Trials studying SION-109

News(1)

Report a data issue

comments(0)